IPO

Zhongji Innolight's $7B Hong Kong IPO Nears Regulatory Nod

Zhongji Innolight is set to launch a $7 billion Hong Kong IPO, pending regulatory approval, which could dilute existing shareholders by up to 6.4%.

Michael Okonkwo · · · 3 min read · 3 views
Zhongji Innolight's $7B Hong Kong IPO Nears Regulatory Nod

Zhongji Innolight (SHE:300308) is nearing a significant milestone as it seeks regulatory clearance from the China Securities Regulatory Commission (CSRC) for a Hong Kong share sale valued at approximately $7 billion. This move, which would represent about 84% of the company's total assets as of the end of March, has garnered substantial investor interest, with the fundraising target previously rising from an initial $5 billion.

Key Financial Implications

The proposed offering, if executed entirely through new shares, would result in a dilution of roughly 3.5% for existing shareholders based on the company's Shenzhen closing price. However, a more realistic scenario, considering a potential 47% discount similar to that seen in Victory Giant Technology's (SHE:300476) recent Hong Kong listing, could lead to a dilution of approximately 6.4%. This discount, while steep, reflects the typical valuation gap between onshore and offshore listings for Chinese firms.

At the reported size, the Innolight offering would exceed Victory Giant's April sale by about $4.4 billion, positioning it among Hong Kong's largest listings in recent years. The proceeds, if fully raised, could more than double the company's book equity before fees, shifting the focus from dilution to capital allocation.

Capital Allocation and Expansion Plans

The company's first-quarter financials reveal a significant pull on funding, with prepayments for materials surging over tenfold to 1.49 billion yuan and construction in progress rising 66% to 2.36 billion yuan. Investing cash outflow reached 1.95 billion yuan as Innolight aggressively expands capacity. At the current quarterly pace, the reported gross proceeds would cover just over six years of investing outflow, indicating a strategic push to build capacity ahead of anticipated demand.

Management's recent comments underscore this approach. Vice President and Board Secretary Wang Jun stated in a July 12 investor call that "orders on hand already cover all of 2026," with some extending into 2027. He also dismissed rumors of a severe second-quarter shortfall as having "no basis" and projected stable gross margins.

Market Context and Supply Constraints

Supply, rather than orders, appears to be the immediate constraint. The company has highlighted ongoing tightness in optical and electrical chips and printed circuit boards, which it has addressed through long-term contracts and advance payments. Wang also noted that reported 2027 price cuts were exaggerated, as few producers can deliver next-generation 1.6-terabit and 800-gigabit modules in volume.

The H-share discount remains a critical factor. Victory Giant's precedent—pricing its Hong Kong sale 47% below its Shenzhen close—resulted in a debut gain of 50.1%, narrowing the discount to about 17%. Winston Ma, executive director of the Global Public Investment Funds Forum, noted that top-end pricing and full exercise of the upsize option demonstrated deep demand for advanced Chinese manufacturing listings.

Investor Considerations

For investors, the issue price and the proportion of primary capital are now more important than the regulatory milestone itself. A deeper discount would require more new shares, while a large secondary component would send less cash to the company. Approval could be delayed, the sale could shrink, and a cheaper Hong Kong price could pressure the Shenzhen valuation. Demand may also cool or supply shortages could hinder shipments.

Innolight's shares closed at 1,169.31 yuan, down 1.24% on the day, though they have gained over 90% this year. The company's market value stands at about 1.3 trillion yuan. At the current exchange rate of roughly 6.8 yuan per dollar, the reported offering converts to about 47.6 billion yuan.

The outcome of this listing will reveal whether Hong Kong is funding the next phase of capacity expansion or setting a lower valuation anchor for Innolight's shares. For now, the market waits for final terms and regulatory approval.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.